Publications
Access Travere’s peer-reviewed publications.
Results 44
Sort by
Efficacy and Safety of ACE Inhibitor and Angiotensin Receptor Blocker Therapies in Primary Focal Segmental Glomerulosclerosis Treatment: A Systematic Review and Meta-Analysis
Sparsentan Improves Glomerular Hemodynamics, Cell Functions, and Tissue Repair in a Mouse Model of FSGS
Population-Level Risk Factors for Kidney Outcomes in IgA Nephropathy: The CURE-CKD Registry
The Humanistic Burden of Focal Segmental Glomerulosclerosis on Patients and Care‑Partners in the United States
Population Risk Predictors of Major Adverse Kidney Events Attributed to FSGS from the CURE-CKD Registry
Long-Term Outcomes in Nephrotic Syndrome by Kidney Biopsy Diagnosis and Proteinuria
Clinical Study Outcomes in IgA Nephropathy: A Systematic Literature Review and Narrative Synthesis
Sparsentan Clinical Trials in Glomerular Diseases: Defining Endpoints and a Path Forward in Light of the Parasol Initiative
Epidemiology and Burden of Focal Segmental Glomerulosclerosis Among United States Veterans: An Analysis of Veterans Affairs Data
The Dual Endothelin A and Angiotension II Type 1 Receptor Antagonist Sparsentan (FILSPARI®) Exhibits a Safe Nonclinical Male Fertility Toxicity Profile
Mechanism of Protective Actions of Sparsentan in the Kidney: Lessons From Studies in Models of Chronic Kidney Disease
The Humanistic Burden of Immunoglobulin A Nephropathy on Patients and Care-Partners in The United States